[Sclerodermiform and poikilodermal syndrome observed during treatment with carbidopa and 5-hydroxytryptophan].
D000368:Aged; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D010859:Pigmentation Disorders / Q000139:chemically induced*; D012594:Scleroderma, Localized / Q000139:chemically induced*
D002230:Carbidopa
Syndrome sclérodermiforme et poïkilodermique observé au cours d'un traitement par carbidopa et 5-hydroxy-tryptophanne.